Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Related structures:
AlphaFold database: A0A3S7WT74
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 102 | 106 | PF00656 | 0.673 |
CLV_MEL_PAP_1 | 248 | 254 | PF00089 | 0.548 |
CLV_NRD_NRD_1 | 21 | 23 | PF00675 | 0.539 |
CLV_NRD_NRD_1 | 292 | 294 | PF00675 | 0.579 |
CLV_NRD_NRD_1 | 99 | 101 | PF00675 | 0.610 |
CLV_PCSK_KEX2_1 | 20 | 22 | PF00082 | 0.467 |
CLV_PCSK_KEX2_1 | 292 | 294 | PF00082 | 0.579 |
CLV_PCSK_KEX2_1 | 99 | 101 | PF00082 | 0.628 |
CLV_PCSK_SKI1_1 | 125 | 129 | PF00082 | 0.708 |
CLV_PCSK_SKI1_1 | 89 | 93 | PF00082 | 0.571 |
DEG_COP1_1 | 279 | 288 | PF00400 | 0.685 |
DEG_Nend_Nbox_1 | 1 | 3 | PF02207 | 0.601 |
DOC_CKS1_1 | 321 | 326 | PF01111 | 0.629 |
DOC_CYCLIN_yCln2_LP_2 | 237 | 243 | PF00134 | 0.339 |
DOC_MAPK_gen_1 | 292 | 300 | PF00069 | 0.424 |
DOC_MAPK_gen_1 | 72 | 81 | PF00069 | 0.504 |
DOC_MAPK_HePTP_8 | 198 | 210 | PF00069 | 0.543 |
DOC_MAPK_MEF2A_6 | 201 | 210 | PF00069 | 0.438 |
DOC_MAPK_MEF2A_6 | 292 | 300 | PF00069 | 0.400 |
DOC_PP1_MyPhoNE_1 | 292 | 299 | PF00149 | 0.545 |
DOC_PP1_RVXF_1 | 9 | 16 | PF00149 | 0.572 |
DOC_PP2B_LxvP_1 | 237 | 240 | PF13499 | 0.573 |
DOC_PP2B_LxvP_1 | 352 | 355 | PF13499 | 0.552 |
DOC_PP2B_LxvP_1 | 48 | 51 | PF13499 | 0.603 |
DOC_USP7_MATH_1 | 121 | 125 | PF00917 | 0.611 |
DOC_USP7_MATH_1 | 158 | 162 | PF00917 | 0.574 |
DOC_USP7_MATH_1 | 181 | 185 | PF00917 | 0.651 |
DOC_USP7_MATH_1 | 225 | 229 | PF00917 | 0.580 |
DOC_USP7_MATH_1 | 233 | 237 | PF00917 | 0.529 |
DOC_USP7_MATH_1 | 311 | 315 | PF00917 | 0.529 |
DOC_USP7_MATH_1 | 38 | 42 | PF00917 | 0.644 |
DOC_USP7_MATH_1 | 49 | 53 | PF00917 | 0.622 |
DOC_WW_Pin1_4 | 145 | 150 | PF00397 | 0.688 |
DOC_WW_Pin1_4 | 211 | 216 | PF00397 | 0.533 |
DOC_WW_Pin1_4 | 320 | 325 | PF00397 | 0.610 |
LIG_14-3-3_CanoR_1 | 107 | 117 | PF00244 | 0.643 |
LIG_14-3-3_CanoR_1 | 168 | 172 | PF00244 | 0.505 |
LIG_14-3-3_CanoR_1 | 274 | 281 | PF00244 | 0.620 |
LIG_BIR_III_4 | 135 | 139 | PF00653 | 0.558 |
LIG_BRCT_BRCA1_1 | 150 | 154 | PF00533 | 0.803 |
LIG_FHA_1 | 203 | 209 | PF00498 | 0.401 |
LIG_FHA_1 | 267 | 273 | PF00498 | 0.557 |
LIG_FHA_2 | 177 | 183 | PF00498 | 0.508 |
LIG_FHA_2 | 277 | 283 | PF00498 | 0.663 |
LIG_LIR_Nem_3 | 12 | 18 | PF02991 | 0.579 |
LIG_Pex14_2 | 330 | 334 | PF04695 | 0.500 |
LIG_PTAP_UEV_1 | 159 | 164 | PF05743 | 0.629 |
LIG_SH2_STAP1 | 263 | 267 | PF00017 | 0.569 |
LIG_SH2_STAP1 | 340 | 344 | PF00017 | 0.447 |
LIG_SH2_STAT5 | 176 | 179 | PF00017 | 0.510 |
LIG_SH2_STAT5 | 18 | 21 | PF00017 | 0.575 |
LIG_SH3_3 | 1 | 7 | PF00018 | 0.582 |
LIG_SH3_3 | 137 | 143 | PF00018 | 0.743 |
LIG_SH3_3 | 157 | 163 | PF00018 | 0.700 |
LIG_SH3_3 | 180 | 186 | PF00018 | 0.690 |
LIG_SH3_3 | 318 | 324 | PF00018 | 0.697 |
LIG_SH3_3 | 53 | 59 | PF00018 | 0.707 |
LIG_TRAF2_1 | 287 | 290 | PF00917 | 0.547 |
LIG_TRAF2_1 | 64 | 67 | PF00917 | 0.523 |
MOD_CK1_1 | 108 | 114 | PF00069 | 0.621 |
MOD_CK1_1 | 147 | 153 | PF00069 | 0.688 |
MOD_CK1_1 | 228 | 234 | PF00069 | 0.533 |
MOD_CK1_1 | 277 | 283 | PF00069 | 0.657 |
MOD_CK1_1 | 41 | 47 | PF00069 | 0.640 |
MOD_CK1_1 | 52 | 58 | PF00069 | 0.718 |
MOD_CK2_1 | 228 | 234 | PF00069 | 0.633 |
MOD_CK2_1 | 276 | 282 | PF00069 | 0.613 |
MOD_CK2_1 | 284 | 290 | PF00069 | 0.563 |
MOD_CK2_1 | 301 | 307 | PF00069 | 0.516 |
MOD_CK2_1 | 61 | 67 | PF00069 | 0.545 |
MOD_GlcNHglycan | 130 | 133 | PF01048 | 0.649 |
MOD_GlcNHglycan | 160 | 163 | PF01048 | 0.574 |
MOD_GlcNHglycan | 195 | 198 | PF01048 | 0.605 |
MOD_GlcNHglycan | 231 | 234 | PF01048 | 0.508 |
MOD_GlcNHglycan | 286 | 289 | PF01048 | 0.558 |
MOD_GlcNHglycan | 40 | 43 | PF01048 | 0.673 |
MOD_GlcNHglycan | 63 | 66 | PF01048 | 0.529 |
MOD_GlcNHglycan | 75 | 78 | PF01048 | 0.476 |
MOD_GSK3_1 | 105 | 112 | PF00069 | 0.608 |
MOD_GSK3_1 | 121 | 128 | PF00069 | 0.410 |
MOD_GSK3_1 | 144 | 151 | PF00069 | 0.726 |
MOD_GSK3_1 | 189 | 196 | PF00069 | 0.725 |
MOD_GSK3_1 | 225 | 232 | PF00069 | 0.558 |
MOD_GSK3_1 | 276 | 283 | PF00069 | 0.632 |
MOD_NEK2_1 | 166 | 171 | PF00069 | 0.528 |
MOD_NEK2_1 | 189 | 194 | PF00069 | 0.713 |
MOD_NEK2_1 | 254 | 259 | PF00069 | 0.550 |
MOD_NEK2_1 | 43 | 48 | PF00069 | 0.662 |
MOD_PIKK_1 | 274 | 280 | PF00454 | 0.638 |
MOD_PK_1 | 301 | 307 | PF00069 | 0.477 |
MOD_PKA_2 | 108 | 114 | PF00069 | 0.643 |
MOD_PKA_2 | 167 | 173 | PF00069 | 0.532 |
MOD_PKB_1 | 107 | 115 | PF00069 | 0.647 |
MOD_PKB_1 | 274 | 282 | PF00069 | 0.655 |
MOD_Plk_1 | 225 | 231 | PF00069 | 0.504 |
MOD_Plk_1 | 233 | 239 | PF00069 | 0.471 |
MOD_Plk_4 | 202 | 208 | PF00069 | 0.407 |
MOD_ProDKin_1 | 145 | 151 | PF00069 | 0.690 |
MOD_ProDKin_1 | 211 | 217 | PF00069 | 0.536 |
MOD_ProDKin_1 | 320 | 326 | PF00069 | 0.607 |
TRG_DiLeu_BaLyEn_6 | 56 | 61 | PF01217 | 0.728 |
TRG_ENDOCYTIC_2 | 10 | 13 | PF00928 | 0.522 |
TRG_ER_diArg_1 | 107 | 110 | PF00400 | 0.666 |
TRG_ER_diArg_1 | 19 | 22 | PF00400 | 0.555 |
TRG_ER_diArg_1 | 291 | 293 | PF00400 | 0.507 |
TRG_ER_diArg_1 | 99 | 101 | PF00400 | 0.684 |
TRG_Pf-PMV_PEXEL_1 | 209 | 213 | PF00026 | 0.494 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1IHA6 | Leptomonas seymouri | 56% | 99% |
A0A1X0NNF4 | Trypanosomatidae | 29% | 89% |
A0A422NFP0 | Trypanosoma rangeli | 35% | 100% |
A4H7V1 | Leishmania braziliensis | 81% | 100% |
A4HW77 | Leishmania infantum | 99% | 100% |
C9ZST9 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 35% | 100% |
E9APX8 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 90% | 100% |
Q4QFK3 | Leishmania major | 90% | 100% |
V5AW09 | Trypanosoma cruzi | 36% | 100% |